# Addus HomeCare Corporation (ADUS) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Health Care Providers. Price $126.55, market value $2.4 billion.

## Valuation
- **P/E (trailing): 22.2×** (5-yr avg 28.6×, 3-yr avg 24.8×). Addus HomeCare Corporation trades at 22.2× trailing earnings, well below its own five-year average of 28.6×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 16.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.72**. A PEG of 0.72 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.6×**. Each dollar of revenue is priced at 1.6×.
- **Price / book: 2.1×**. The shares trade at 2.1× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 15.1×**. Enterprise value is 15.1× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 6.5%** (5-yr avg 5.1%). Free cash flow equals 6.5% of the market value, above its five-year average of 5.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 4.5%**. The inverse of the P/E: 4.5% of the price is earned each year.

## Profitability
- **Gross margin: 32.4%**. Addus HomeCare Corporation keeps 32.4% of revenue after the direct cost of what it sells.
- **Operating margin: 10.0%**. 10.0% of revenue is left after running the business.
- **Net margin: 6.7%**. 6.7% of each dollar of sales reaches the bottom line.
- **Return on equity: 8.8%**. 8.8% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 9.7%**. Return on all capital, debt included, is 9.7%.
- **Return on assets: 7.3%**. Each dollar of assets produces 7.3% of profit.

## Growth
- **Revenue growth (1 yr): 23.2%** (3-yr 14.4%/yr, 5-yr 13.2%/yr). Revenue grew 23.2% over the last year, against 13.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 23.4%** (3-yr 22.5%/yr, 5-yr 20.2%/yr). Earnings per share rose 23.4%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 2.3%/yr**. Free cash flow has compounded at 2.3% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.11**. Debt is 0.11 times equity: a conservative balance sheet.
- **Current ratio: 1.80** (quick 1.80). Current assets cover the next year's liabilities 1.80 times.
- **Altman Z-score: 6.49**. A Z-score of 6.49 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend: none**. Addus HomeCare Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (13 analysts). 13 analysts cover Addus HomeCare Corporation; the consensus is buy, with an average price target of $134.08 (+6% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 7.6%** (YTD 17.1%, 3-mo 7.7%). The shares are up 7.6% over twelve months including dividends.
- **From 52-week high: -0.4%** (43.9% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 73**. An RSI of 73 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.17** (volatility 29%). Beta of 0.17 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ADUS · Page: https://foliofundamentals.com/stocks/adus

Not investment advice.